Spiritus Mundi PLC
SPMU
Company Profile
Business description
Spiritus Mundi PLC is a special-purpose acquisition company incorporated in the United Kingdom. The company’s only segment is to Identify and acquire investment projects in the clinical diagnostics sector which includes Clinical laboratory services (clinical lab); Clinical Diagnostics (PCR and blood test); and Digital Health (Healthcare IT platform).
Contact
Westend's offices at 6 Heddon Street
LondonW1B 4BT
GBRSector
Financial Services
Stock type
Cyclical
Industry
Shell Companies
Fiscal Year End
30 September 2027
Employees
Stocks News & Analysis
stocks
Meta earnings: Early look at Muse adoption impresses investors
We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.
stocks
Tesla earnings: Shares fall on slower deliveries growth outlook; Raising valuation
Our increased valuation comes from higher full self-driving adoption assumptions and a lower near- and medium-term capital expenditures forecast.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,905.80 | 11.30 | -0.13% |
| CAC 40 | 7,752.31 | 58.95 | -0.75% |
| DAX 40 | 25,156.73 | 215.02 | -0.85% |
| Dow JONES (US) | 52,867.98 | 11.89 | 0.02% |
| FTSE 100 | 10,665.86 | 59.17 | -0.55% |
| HKSE | 23,093.37 | 158.69 | 0.69% |
| NASDAQ | 26,008.86 | 694.00 | -2.60% |
| Nikkei 225 | 62,693.16 | 214.68 | -0.34% |
| NZX 50 Index | 13,733.93 | 12.91 | -0.09% |
| S&P 500 | 7,663.43 | 93.74 | -1.21% |
| S&P/ASX 200 | 8,795.20 | 2.00 | 0.02% |
| SSE Composite Index | 3,690.48 | 32.45 | 0.89% |